The novel anti-cancer fluoropyrimidine NUC-3373 is a potent inhibitor of thymidylate synthase and an effective DNA-damaging agent
Article in Cancer Chemotherapy and Pharmacology (March 2023)
The most recent citing publications are shown below. View all 43 publications that cite this research output on Dimensions.
Article in Cancer Chemotherapy and Pharmacology (March 2023)
Article in Carcinogenesis (November 2022)
Article in Medical Oncology (October 2022)